COPD

October 20 - 21, 2014 - London UK

SMI Group Ltd

tarri@smi-online.co.uk
Phone:+44 020 7827 6162

The 6th instalment in the successful COPD series has evolved to cover topics such as as patient care, exacerbation and comorbidities, clinical trial design, drug development and market access. With the global COPD market forecasted to reach a value of $15.6 billion by 2019, COPD 2014 comes at a perfect time to provide the industry with a niche platform for discussion and a forum to learn from KOL's and visionaries in the field of COPD.

More Information